DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1-Reference-Cited by-同舟云学术

DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1

Published:2018-05 Issue:5 Volume:9 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Cui Tiantian,Srivastava Amit Kumar,Han Chunhua,Wu Dayong,Wani Nissar,Liu Lu,Gao Zhiqin,Qu Meihua,Zou Ning,Zhang Xiaoli,Yi Ping,Yu Jianhua,Bell Erica H.,Yang Shyh-Ming,Maloney David J.,Zheng Yanfang,Wani Altaf A.,Wang Qi-En

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-018-0585-y.pdf

Reference48 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30 (2016).

2. Hennessy, B. T., Coleman, R. L. & Markman, M. Ovarian cancer. Lancet 374, 1371–1382 (2009).

3. Hermann, P. C., Huber, S. L. & Heeschen, C. Metastatic cancer stem cells: a new target for anti-cancer therapy? Cell Cycle 7, 188–193 (2008).

4. Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5, 275–284 (2005).

5. Nguyen, L. V., Vanner, R., Dirks, P. & Eaves, C. J. Cancer stem cells: an evolving concept. Nat. Rev. Cancer 12, 133–143 (2012).

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor cells: from new biological insights to clinical practice;Signal Transduction and Targeted Therapy;2024-09-02

2. Targeting Cancer Stem Cells with Radioimmunotherapy: The Case of the Ovarian Cancer Stemness-Associated Biomarker L1CAM;International Journal of Translational Medicine;2024-07-18

3. Advances in ovarian tumor stem cells and therapy;Cell Biochemistry and Biophysics;2024-07-03

4. Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer;Nature Communications;2024-02-13

5. FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells;Neoplasma;2024